Skip to main content
APLS logo

APLS · Apellis Pharmaceuticals, Inc.

Track APLS — free
Market Cap
$5.25B
Shares
128.02M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024
Executive Total
Cedric Francois $10,957,451
Caroline Baumal $4,407,128
Adam Townsend $3,956,053
Timothy Sullivan $3,949,075
David Watson $3,891,721
Fiscal 2023
Executive Total
Cedric Francois $10,373,049
David Watson $4,885,889
Caroline Baumal $4,430,459
Timothy Sullivan $3,737,235
Adam Townsend $3,714,246
Fiscal 2022
Executive Total
Cedric Francois $9,203,556
Timothy Sullivan $3,546,148
Adam Townsend $3,096,029
Pascal Deschatelets $3,082,479
David Watson $3,069,773
Fiscal 2021
Executive Total
Cedric Francois $9,122,039
Timothy Sullivan $3,075,916
Pascal Deschatelets $2,647,975
Adam Townsend $2,640,819
Federico Grossi $2,616,139
Fiscal 2020
Executive Total
Cedric Francois $9,275,425
Timothy Sullivan $3,485,149
Nur Nicholson $3,022,154
Pascal Deschatelets $2,918,082
Adam Townsend $2,901,007
Fiscal 2019
Executive Total
Cedric Francois $4,267,182
Lucia Celona $3,763,062
Thomas Lackner $2,108,720
Pascal Deschatelets $1,821,228
Timothy Sullivan $1,719,303
Fiscal 2018
Executive Total
Cedric Francois $4,074,540
Pascal Deschatelets $1,862,357
Timothy Sullivan $859,752
Fiscal 2017
Executive Total
Timothy Sullivan $2,296,699
Cedric Francois $1,662,972
Pascal Deschatelets $869,548

Executive changes

Person Change Filed
Mikael Dolsten, M.D., Ph.D. Appointed 2026-03-02
Craig A. Wheeler Appointed 2025-04-21
Adam Townsend Resigned 2025-01-13
Keli Walbert Appointed 2025-01-13
Adam Townsend Appointed 2024-01-22
Dr. Caroline Baumal Appointed 2023-01-09
Caroline Baumal, M.D. Appointed 2023-01-05
Key facts CIK 1492422 CUSIP 03753U106 13F (30d) 8 filings 5 filers Visit website